Literature DB >> 7688267

Expression of IL-4 receptor on human T and B lymphocytes.

H Zola1, L Flego, H Weedon.   

Abstract

The expression of the interleukin-4 receptor on human blood and tonsil lymphocytes has been studied using a monoclonal antibody and high-sensitivity immunofluorescence flow cytometry. While no receptor expression could be detected on circulating or tonsil T cells, a subset of B cells was shown to express the receptor. The IL-4R-positive B cells in tonsil had a phenotype suggesting that they included both germinal centre B cells and B cells outside the germinal centre. The subset of B cells in the blood that expressed the receptor included CD23-positive B cells. Activation of tonsil B cells using anti-IgM, IL-4, IL-2, or combinations of these reagents led to increases in IL-4R expression, but these changes were small compared to changes in the expression of IL-2R p55 (CD25), a known marker of activation. Similarly, activation of T cells led to low-level expression of IL-4R, with IL-4 itself up-regulating IL-4R, especially in CD4 cells. The majority of chronic lymphocytic leukaemia samples were positive for IL-4R expression, whilst most other leukemic samples were negative.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7688267     DOI: 10.1006/cimm.1993.1186

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  2 in total

1.  Reduced expression of the interleukin-2-receptor gamma chain on cord blood lymphocytes: relationship to functional immaturity of the neonatal immune response.

Authors:  H Zola; M Fusco; H Weedon; P J Macardle; J Ridings; D M Roberton
Journal:  Immunology       Date:  1996-01       Impact factor: 7.397

2.  Molecular and Cellular Responses to Interleukin-4 Treatment in a Rat Model of Transient Ischemia.

Authors:  Starlee Lively; Sarah Hutchings; Lyanne C Schlichter
Journal:  J Neuropathol Exp Neurol       Date:  2016-11-01       Impact factor: 3.685

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.